Select Net Receivables from 2010 to 2025

SEM Stock  USD 16.86  0.30  1.81%   
Select Medical Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 612.6 M. During the period from 2010 to 2025, Select Medical Net Receivables quarterly data regression pattern had sample variance of 49797.7 T and median of  691,732,000. View All Fundamentals
 
Net Receivables  
First Reported
2006-06-30
Previous Quarter
1.1 B
Current Value
821.4 M
Quarterly Volatility
256.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 139.7 M, Interest Expense of 151.7 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0261 or PTB Ratio of 1.47. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
  
Check out the analysis of Select Medical Correlation against competitors.

Latest Select Medical's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Select Medical Holdings over the last few years. It is Select Medical's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Select Net Receivables Regression Statistics

Arithmetic Mean644,133,170
Geometric Mean602,916,193
Coefficient Of Variation34.64
Mean Deviation187,139,705
Median691,732,000
Standard Deviation223,153,953
Sample Variance49797.7T
Range684.5M
R-Value0.85
Mean Square Error14687.4T
R-Squared0.72
Significance0.000029
Slope39,902,142
Total Sum of Squares746965.3T

Select Net Receivables History

2025612.6 M
2024821.4 M
2023940.3 M
2022941.3 M
2021889.3 M
2020896.8 M
2019762.7 M

About Select Medical Financial Statements

Select Medical investors utilize fundamental indicators, such as Net Receivables, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables821.4 M612.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:
Check out the analysis of Select Medical Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.139
Dividend Share
0.438
Earnings Share
0.51
Revenue Per Share
41.625
Quarterly Revenue Growth
(0.21)
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.